A unique facility containing Biosafety Level 3 (BSL3) and Animal Biosafety Level 3 (ABSL3) laboratories. The facility houses dedicated environments for aerobiology, imaging and immunopathology.
The University of Pittsburgh has consistently been ranked among the top 10 in National Institutes of Health (NIH) funding during the past decade, and the Center for Vaccine Research (CVR) at the University of Pittsburgh brings together scientists from varied disciplines with a common goal of investigating the pathogenesis and immunology of emerging infectious diseases and biodefense pathogens.
The CVR investigators conduct research on BSL-3 Category A, B, and C priority pathogens that have an impact on the health of people around the work.
Learn more about what goes on in the RBL.
Frequently Asked Questions
Learn about our facility further by exploring the frequently asked questions.
For information on potential collaboration or contract, please complete a contact form and a representative will contact you as soon as possible.